Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

10-14 Earnings release - Q2 2026

More about the company

07-23	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
07-09	Theraclion Announces Board Changes	CI

Market Cap	44.6M 51.39M 41.76M 38.2M 72.11M 4.9B 73.06M 489M 192M 2.45B 193M 189M 8.14B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	52.45M 60.44M 49.11M 44.92M 84.81M 5.76B 85.92M 575M 225M 2.88B 227M 222M 9.57B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

07-23	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris

07-23	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
07-15	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
07-09	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU

07-23	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
07-15	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
07-09	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07-09	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer

THERACLION N Share Price Euronext Paris

Stocks

FR0010120402

Advanced Medical Equipment & Technology

Valuation: THERACLION N

Latest news : THERACLION N

Press Releases: THERACLION N

News in other languages: THERACLION N

Managers and Directors: THERACLION N

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	23/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	31/01/2018
Ari Kellen BRD	Director/Board Member	-	12/02/2019
Shawn Langer BRD	Director/Board Member	-	12/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERMO FISHER SCIENTIFIC, INC.	-0.40%	-0.25%	+28.16%	+4.27%	214B
DANAHER CORPORATION	-0.46%	+1.27%	+1.79%	-22.29%	140B
INTUITIVE SURGICAL, INC.	-0.11%	+6.30%	-20.85%	+21.33%	133B
BOSTON SCIENTIFIC CORPORATION	+3.88%	+8.01%	-51.74%	-2.06%	69.19B
EDWARDS LIFESCIENCES CORPORATION	+0.08%	+2.49%	+13.33%	+11.58%	51.28B
SIEMENS HEALTHINEERS AG	-0.36%	+5.11%	-14.27%	-19.86%	50.43B
AGILENT TECHNOLOGIES, INC.	-0.38%	+1.20%	+23.97%	+10.96%	39.85B
WATERS CORPORATION	-1.05%	+4.06%	+42.50%	+36.60%	39.27B
RESMED, INC.	+0.27%	+7.65%	-19.95%	+20.28%	32.32B
Average	+0.19%	+3.77%	+0.33%	+6.76%	85.43B
Weighted average by Cap.	+0.07%	+3.04%	+2.43%	+3.37%

	2024	2025
Net sales	830K 957K 777K 711K 1.34M 91.13M 1.36M 9.09M 3.57M 45.53M 3.59M 3.51M 152M	652K 751K 611K 558K 1.05M 71.57M 1.07M 7.14M 2.8M 35.76M 2.82M 2.76M 119M
Net income	-5.76M -6.63M -5.39M -4.93M -9.31M -632M -9.43M -63.07M -24.75M -316M -24.91M -24.37M -1.05B	-5.69M -6.56M -5.33M -4.87M -9.2M -625M -9.32M -62.33M -24.46M -312M -24.62M -24.08M -1.04B
Net Debt	3.41M 3.93M 3.19M 2.92M 5.52M 374M 5.59M 37.36M 14.66M 187M 14.76M 14.44M 623M	7.85M 9.05M 7.35M 6.73M 12.7M 862M 12.86M 86.02M 33.76M 431M 33.97M 33.23M 1.43B

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-